ImportRefusal LogoImportRefusal

Regenaplex Homoopathische

⚠️ Moderate Risk

FEI: 3005673253 • Constance • GERMANY

FEI

FEI Number

3005673253

📍

Location

Constance

🇩🇪

Country

GERMANY
🏢

Address

Robert-Bosch-Str.3, , Constance, , Germany

Moderate Risk

FDA Import Risk Assessment

30.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
2
Unique Violations
5/2/2006
Latest Refusal
5/2/2006
Earliest Refusal

Score Breakdown

Violation Severity
65.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1171×

DANGEROUS

The article appears to be dangerous to health when used in the dosage or manner, or with the frequency or duration, prescribed, recommended, or suggested in the labeling thereof.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
5/2/2006
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
117DANGEROUS
472NO ENGLISH
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Regenaplex Homoopathische's FDA import refusal history?

Regenaplex Homoopathische (FEI: 3005673253) has 1 FDA import refusal record(s) in our database, spanning from 5/2/2006 to 5/2/2006.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Regenaplex Homoopathische's FEI number is 3005673253.

What types of violations has Regenaplex Homoopathische received?

Regenaplex Homoopathische has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Regenaplex Homoopathische come from?

All FDA import refusal data for Regenaplex Homoopathische is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.